1 | Global Immunization Meeting: PIA Sitges, 23-25 June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination.

Slides:



Advertisements
Similar presentations
UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Advertisements

Polio Communication Indicators Reflections from Polio Communication TAG/Review Process.
Impact of Large-Scale Infant Feeding Promotion on Child Survival and Health in Madagascar.
Global Measles and Rubella Strategic Plan
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Pentavalent vaccine Introduction in UIP in India:
Common Problems & Solutions to High Routine Immunization Coverage An Introduction to the RED strategy.
Monitoring & Evaluation for Routine Immunization: Data For Action
Reproductive and Child Health (R&CH) Presented by: Dr. Mariam J. Bakar & Mr. Yusuph Haji.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
Strengthening Routine Infant Immunization in EMR Partners for Measles Advocacy February, 2007 Eastern Mediterranean Regional Office Vaccines Preventable.
MINISTRY OF COMMUNITY DEVELOPMENT MOTHER AND CHILD HEALTH MRS. ELIKA KAMIJI CHIEF EPI OFFICER IMPLEMENTATION OF GAPPD: ZAMBIAN EXPERIENCE Global Immunization.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Supporting Routine AND Supplementary Immunization Activities in STOP.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Invalid MCV1 doses – how big a problem? B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
Data that Walk and Talk Presented by: JSI/Boston Brown Bag 22 February 2008.
Routine Immunization: The Missed Child Perspective Maya van den Ent, PharmD MPH Edward Hoekstra, MD, MSc David Brown, DSc, MScPH, MSc Halima Dao, MD, MSc.
1 AFRO Measles TAG – Nairobi 2-3 June 2015 MCV2 Introduction and the Second Year of Life Contact Lessons and way forward Raoul KAMADJEU UNICEF ESARO Meeting.
Health Cluster Response Plan CAP 2013 SANA”A, YEMEN October 20 th, 2012.
Integration of postnatal care with PMTCT: Experiences from Swaziland
The Reaching Every District (RED) strategy.  Re-establish outreach services  Conduct supportive supervision  Establish community links with service.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Data management update in the AFR; ARCI, Dar-es-Salaam, Tanzania, December | Presentation outline  Background  Gaps in data management.
Antenatal care MDG 5, Target 5b, Indicator 5.5
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
MDG Needs Assessment Training Workshop May 9-12, 2005 Health Module.
Roadmap Progress Report 2011 Zambia SARN-RBM PARTNERS ANNUAL CONSULTATIVE MEETING, JULY 2011.
Expanded Program of Immunization Dr. Faten M. Rabie.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Short Programme Review on Child Health Experience from Sri Lanka Family Health Bureau Ministry of Health Sri Lanka 1 Regional Programme Managers Meeting.
Primer on Monitoring and Evaluation. The 3 Pillars of Monitoring and Evaluation  Identifying the Performance Indicators  Collecting information using.
Tracking Scale Up of Maternal and Newborn Health Interventions Jeffrey M. Smith MCHIP Interventions for Impact in Essential Obstetric and Newborn Care.
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Update on Measles Mortality Reduction Activities and Linkages with RI.
Country Report Progress Toward Strengthening EPI [Country Name]
Global Strategy On Infant and Young Child Feeding State of Implementation in the context of MDG4 Country – India South Asia Breastfeeding Partners Forum.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
WBT in South Asia Dr.S.K.Roy Senior Scientist, ICDDR’B and Secretary, BBF.
Funding Update: 2013 – 2015 September 10,
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Dr, Janbaz Afridi Deputy Director EPI Khyber Pakhtunkhwa
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
MDG 4 Target: Reduce by two- thirds, between 1990 & 2015, the mortality rate of children under five years.
Early Essential Newborn Care Progress Findings of the Independent Review Group on EENC 21 September, 2015 Tokyo, Japan.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
GHANA HEALTH SERVICE, EASTERN REGION MID-YEAR REVIEW 2014 WAY FORWARD BY RDHS.
The South African Mother Baby Friendly Initiative Experience
INTRODUCTION TO INFORMATION SYSTEMS FOR IMMUNIZATION SERVICES IPV Global Workshop March 2014.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
Definition of indicators Facilitators’ Workshop on District Health Performance Improvement Lilongwe, 25 th – 27 th March 2015.
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
DHPI Approach at a Glance Facilitators’ Workshop on District Health Performance Improvement Lilongwe, 25 th – 27 th March 2015.
Maternal and Neonatal Tetanus Elimination (MNTE) in Kenya Dr Collins Tabu, National Vaccines and Immunization Program Ministry of Health, Kenya.
Innovations: Measles Programmatic Risk Assessments
Measles SIA Readiness Assessment-Uganda Experience
World Health Organization
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
Stakeholder Consultation
World Health Organization
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Partners for Measles Advocacy—7th Annual Meeting
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Presentation transcript:

1 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination - Objectives Highlight tools and strategies for getting back on track for GVAP tetanus and measles/rubella elimination goals Guidelines and tools – MNTE pre-validation “high-risk” assessment guidelines – Programme risk assessment tool – Global guidelines for conducting SIAs with injectable vaccines (including SIA readiness assessment tool)

2 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination– Issues Discussed High-risk MNTE approach – Immunize ALL women of reproductive age in high and medium risk areas – Risk assessment – Core Indicators: Neonatal Tetanus (NT) rate, Access to skilled birth attendants (SBA), TT2+ / PAB coverage rate Surrogate indicators: Antenatal Care (ANC1 & ANC4), Penta/DTP coverage (DTP1 and DTP3), Human Development Index – High Risk districts: 3 rounds 0, 1, 6 months – Medium Risk districts: 2 rounds 0, 1 month

Algorithm – to determine NT risk status Is NT rate < 1/1000 LB ? No High Risk Yes Is district NT surveillance sensitive 1 ? Yes Low Risk No Is reported district clean delivery 2 coverage ≥ 70%? Low Risk YesNo Is TT2+/PAB coverage ≥ 80% from routine among pregnant women (or child-bearing aged women in past 5 years) or SIAs (in all 3 rounds)? Low Risk Yes No High Risk 1. Sensitive = a. existence of zero reporting; b. completeness of reporting from all reporting sites ≥ 80%; c. adequate number/distribution of reporting sites (subjective judgement); d. conduct of record reviews at least once annually or active surveillance in local hospital(s); e. if rural, functional community surveillance (subjective judgement); f. detection of neonatal deaths. 2. Defined as delivery by a physician, nurse or trained midwife. MNTE

Risk Assessment to continue – even after completion of activities 1. Review progress and reassess the risk If country claims that all activities completed 2. Pre-validation Assessment 3. Send request to WHO for Validation Passed LQA Survey Gaps – go for corrective action Reassess 4. Celebrate & Sustain !!! Passed Identify and bridge gaps MNTE Failed

5 | Global Immunization Meeting: PIA Sitges, June 2015 Strategies to sustain MNTE Achieved MNTE without Td SIAs o maintain more than 80% TT/Td at sub national (RED/REC) o &/or increase and maintain more than 70% clean delivery Conducted focused TT/Td SIAs in <20% of districts o annual review of district performance to identify medium and high risk districts o use opportunities such as CHDs/MCHW, PIRI, cMYP planning to increase TdCV Conducted large scale TT SIAs o annual review of district performance to identify medium and high risk districts o conducting corrective SIAs & using opportunities such as CHDs/MCHW, PIRI, cMYP o strengthen surveillance including community based surveillance

6 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination– Issues Discussed Measles Risk Assessment Tool – New tool for assessing measles programmatic risk at district level – Uses a combination of factors/indicators of risk, including vaccination coverage – Can help identify at-risk areas for prioritizing programmatic activities – Able to show variation in risk among districts Not for predicting outbreaks but rather for preventing them To guide and prioritize programmatic action, e.g., – Annual updates to monitor progress, supplemental immunization activity (SIA) planning, outbreak response immunization (ORI) planning, measles case-based surveillance reviews and routine immunization (EPI) reviews, supervisory visits, advocacy and resource mobilization

7 | Global Immunization Meeting: PIA Sitges, June 2015 Measles Programmatic Risk Assessment – Maximum Risk Points for Each Category Range of possible scores: *Each category has a list of indicators with various cut-off criteria to assign risk points District-level risk calculated based on data inputs in 4 main categories:

8 | Global Immunization Meeting: PIA Sitges, June 2015 Measles programmatic risk assessments Zimbabwe Senegal Namibia Philippines Shan Dong Province China Nepal Laos Sudan Uttarakhand State, India

9 | Global Immunization Meeting: PIA Sitges, June 2015 Comparison of Measles SIA Administrative vs. Survey Coverage, African Region,

10 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination– Issues Discussed SIA Field Guide: Reaching the 5 th Child Systems approach to SIAs – A-Z guide for planning, implementing, monitoring and evaluating all SIAs with injectable vaccines – SIAs as opportunities for RI strengthening Focus on reaching the hard to reach – Identification of hard to reach/high risk groups – Vaccination strategies for the hard to reach/high risk group Improve monitoring and data quality – Use of vaccination cards – SIA preparedness assessment guide – Revised RCM – Post SIA evaluation Emphasis on integration (M and R, other health intervention) etc.

11 | Global Immunization Meeting: PIA Sitges, June 2015 SIA Preparedness Assessment Tool – National Level

12 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination – Issues discussed Measles SIA guide, con’t – Preparedness assessment to guide preparation of SIAs and for corrective action Assessing preparation essential to ensuring quality campaign Helpful motivational tool Takes a snapshot of state of preparation at different points in time, and “quantifies” the level of preparedness against the expected activities at that point in time Experience from AFRO (Tanzania, Eritrea, Mauritania) and Afghanistan –Local adaptation and context –Structured visits useful; may need to limited to high risk districts Linking to MCV2 introduction (incorporating messages into SIA training) and checklist

13 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination – Recommendations/Next Steps MNTE – Continue use of High Risk Strategy in countries prior to elimination validation – After validation, continue periodic review of risk w using risk assessment tool and implement corrective measures where necessary to sustain MNT elimination status Measles risk assessment tool – Review utility of risk assessment tool after several years version 2.0 – include more RI indicators, regional risk (beyond immediate borders) – Continue practice of doing population susceptibility profile (accumulation of susceptibles) – If possible, use tool annually at country level to determine high-risk districts – Use tool for RVC to document district-level status over time – Use tool as broader diagnostic check on EPI program SIA field guide – Continue w pilots and roll out of elements of different elements field guide – Campaign preparedness tool : Early introduction, local adaptation, technical assistance; use as part of regular reporting to ICC and partners; use as national management tool Connection with polio strategies; use as readiness vs assessment guide